Botox shot into bladder during prostate surgery may ease urgent bathroom trips

NCT ID NCT05878951

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tests whether injecting Botox into the bladder wall during a standard prostate surgery (HoLEP) can better control overactive bladder symptoms like sudden urges to urinate and leakage. About 66 men aged 18-89 with these symptoms will be randomly assigned to get Botox or a placebo during surgery. Researchers will track symptom improvement and side effects for several months.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
Botox (onabotulinumtoxinA)
What this could lead to
If it works, this could offer a way to reduce urgent, frequent urination and leakage in men already undergoing prostate surgery, improving their quality of life.
What could go wrong
This is a small, early-to-mid-stage trial, so results may not apply to all men. Risks include temporary urinary retention, bleeding, or infection after the procedure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OVERACTIVE BLADDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Northwestern Medicine

    RECRUITING

    Chicago, Illinois, 60611, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.